Brief: ARS Pharmaceuticals Q1 Operating Income USD -37.177 Million
14/05/2025 12:53
May 14 (Reuters) - ARS Pharmaceuticals Inc SPRY.O: ARS PHARMACEUTICALS Q1 OPERATING INCOME USD -37.177 MILLION VERSUS. IBES ESTIMATE USD -37.1 MILLION ARS PHARMACEUTICALS Q1 OPERATING EXPENSES USD 45.15 MILLION ARS PHARMACEUTICALS Q1 REVENUE USD 7.763 MILLION VERSUS. IBES ESTIMATE USD 7.48 MILLION ARS PHARMACEUTICALS Q1 NET INCOME USD -33.94 MILLION VERSUS. IBES ESTIMATE USD -34.6 MILLION ARS PHARMACEUTICALS Q1 BASIC EPS USD -0.35 ARS PHARMACEUTICALS Q1 CASH & INVESTMENTS USD 275.7 MILLION Source text: ID:nGNX9W08PG Further company coverage: SPRY.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ARS Pharmaceuticals
See all newsARS Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
ARS Pharmaceuticals Q2 neffy revenue rises as epinephrine market share doubles
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
ARS Pharma tumbles as allergy nasal spray faces insurance coverage hurdle